Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Imbruvica (ibrutinib). Show all posts
Showing posts with label Imbruvica (ibrutinib). Show all posts
Tuesday, May 24, 2016

FDA Approves Imbruvica (ibrutinib) for the First-Line Treatment of Chronic Lymphocytic Leukemia

›
In continuation of my update on  Ibrutinib   AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced the U.S. Foo...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.